Total Payments
$6,372
2024 Payments
$130.49
Companies
34
Transactions
315
Medicare Patients
424
Medicare Billing
$24,476
Payment Breakdown by Category
Food & Beverage$6,372 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,372 | 315 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,053 | 56 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $874.96 | 32 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $733.37 | 29 | $0 (2023) |
| Optinose US, Inc. | $574.63 | 38 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $466.34 | 24 | $0 (2024) |
| Genentech USA, Inc. | $358.56 | 14 | $0 (2021) |
| GENZYME CORPORATION | $279.90 | 13 | $0 (2023) |
| Greer Laboratories, Inc. | $220.93 | 15 | $0 (2019) |
| ABBVIE INC. | $217.30 | 12 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $176.59 | 14 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $130.49 | 7 | PFIZER INC. ($59.79) |
| 2023 | $224.17 | 11 | Regeneron Healthcare Solutions, Inc. ($79.18) |
| 2022 | $1,357 | 75 | OptiNose US, Inc. ($269.16) |
| 2021 | $802.49 | 50 | Optinose US, Inc. ($155.70) |
| 2020 | $445.70 | 24 | GlaxoSmithKline, LLC. ($94.01) |
| 2019 | $889.08 | 31 | AstraZeneca Pharmaceuticals LP ($185.26) |
| 2018 | $1,388 | 61 | Novartis Pharmaceuticals Corporation ($326.46) |
| 2017 | $1,135 | 56 | Genentech USA, Inc. ($255.78) |
All Payment Transactions
315 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: PAIN | ||||||
| 03/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: IMMUNOLOGY | ||||||
| 02/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: PAIN | ||||||
| 02/20/2024 | WATERMARK MEDICAL, INC. | ARES 620 UNICORDER (Device) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: VENTILATORY EFFORT RECORDER | ||||||
| 01/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: PAIN | ||||||
| 01/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/15/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/05/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: IMMUNOLOGY | ||||||
| 06/29/2023 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 05/16/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/08/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/03/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/17/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.75 | General |
| Category: Immunology | ||||||
| 03/20/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/07/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/24/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: NEUROLOGY | ||||||
| 12/21/2022 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: BIOLOGIC | ||||||
| 12/14/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/14/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $8.12 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/07/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.11 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: PRIMARY CARE | ||||||
| 12/06/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/30/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: PRIMARY CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 51 | 60 | $8,005 | $2,958 |
| 2022 | 8 | 154 | 175 | $22,947 | $8,434 |
| 2021 | 6 | 101 | 109 | $16,005 | $5,986 |
| 2020 | 5 | 118 | 132 | $19,610 | $7,098 |
Total Patients
424
Total Services
476
Medicare Billing
$24,476
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 24 | $3,600 | $1,685 | 46.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 17 | $2,125 | $644.51 | 30.3% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 15 | 19 | $2,280 | $628.43 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 52 | $7,800 | $3,568 | 45.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 17 | 17 | $2,550 | $967.93 | 38.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,475 | $802.16 | 32.4% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 17 | 23 | $2,760 | $796.40 | 28.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 19 | $2,375 | $748.74 | 31.5% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2022 | 17 | 17 | $2,040 | $717.17 | 35.2% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2022 | 18 | 19 | $1,672 | $596.86 | 35.7% |
| 92567 | Test to assess middle ear function | Office | 2022 | 16 | 17 | $1,275 | $237.17 | 18.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 46 | $6,900 | $3,135 | 45.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $2,475 | $702.94 | 28.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 12 | $1,500 | $569.52 | 38.0% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 13 | 15 | $1,800 | $565.18 | 31.4% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2021 | 14 | 14 | $1,680 | $519.96 | 31.0% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 11 | 11 | $1,650 | $493.44 | 29.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 60 | 72 | $10,800 | $3,846 | 35.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 16 | $3,200 | $1,457 | 45.5% |
| 69210 | Removal of impact ear wax, one ear | Office | 2020 | 15 | 16 | $1,920 | $625.50 | 32.6% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2020 | 17 | 17 | $2,040 | $594.54 | 29.1% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 11 | 11 | $1,650 | $574.63 | 34.8% |
About Dr. Barbara Guillette, M.D
Dr. Barbara Guillette, M.D is a Otolaryngology healthcare provider based in Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871656611.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barbara Guillette, M.D has received a total of $6,372 in payments from pharmaceutical and medical device companies, with $130.49 received in 2024. These payments were reported across 315 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($6,372).
As a Medicare-enrolled provider, Guillette has provided services to 424 Medicare beneficiaries, totaling 476 services with total Medicare billing of $24,476. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Location Warwick, RI
- Active Since 12/19/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Y00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1871656611
Products in Payments
- NUCALA (Biological) $747.26
- DUPIXENT (Biological) $673.52
- XOLAIR (Biological) $616.68
- Xhance (Drug) $574.63
- FASENRA (Drug) $520.18
- Xolair (Biological) $358.56
- NURTEC ODT (Drug) $305.01
- BREO (Drug) $181.52
- UBRELVY (Drug) $166.39
- Oralair (Drug) $153.55
- FASENRA (Biological) $128.03
- TEZSPIRE (Biological) $115.20
- TRELEGY ELLIPTA (Drug) $106.50
- Aimovig (Biological) $95.92
- Dymista (Drug) $95.31
- TUDORZA PRESSAIR (Drug) $91.02
- XPRESS ENT DILATION SYSTEM (Device) $80.78
- AUVI-Q (Drug) $78.72
- DUPIXENT (Drug) $72.72
- ORALAIR (Biological) $67.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Warwick
Dr. Mark Andreozzi, D.o, D.O
Otolaryngology — Payments: $18,261
Otolaryngology $18,261
Dr. Alejandro Vazquez, Md, MD
Otolaryngology — Payments: $13,866
Otolaryngology $13,866
Dr. Amit Patel, Md, MD
Otolaryngology — Payments: $6,877
Otolaryngology $6,877
George Jacewicz, M.d, M.D
Otolaryngology
Otolaryngology